GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
44 hedge funds and large institutions have $27.2M invested in Aevi Genomic Medicine Inc in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
44
Holding in Top 10
–
Calls
$27K
Puts
–
Top Buyers
| 1 | +$2.3M | |
| 2 | +$368K | |
| 3 | +$199K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$176K |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$101K |
Top Sellers
| 1 | -$80.2K | |
| 2 | -$50K | |
| 3 | -$37K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$32.1K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$27.2K |